35 Recruiting Idiopathic Pulmonary Fibrosis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Idiopathic Pulmonary Fibrosis Studies
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Atezolizumab for Idiopathic Pulmonary Fibrosis
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
📍 Trial Management Group Inc — Windsor, Ontario
View Study & Checklist ➔Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts
View Study & Checklist ➔A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
📍 Research Site — Quilmes, Buenos Aires
View Study & Checklist ➔Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF
📍 Medical Surgical Associates Center — St John's,
View Study & Checklist ➔The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
📍 Pulmonary Specialists of The Palm Beaches — Loxahatchee Groves, Florida
View Study & Checklist ➔Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
📍 UPMC Presbyterian — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
📍 Local Institution - 0189 — Birmingham, Alabama
View Study & Checklist ➔Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
📍 Instituto Ave Pulmo — Mar del Plata, Buenos Aires
View Study & Checklist ➔LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
📍 University of Washington Medical Center — Seattle, Washington
View Study & Checklist ➔Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
📍 Snyder Building 480 Ray C. Hunt Drive — Charlottesville, Virginia
View Study & Checklist ➔Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
📍 Cedars-Sinai — Los Angeles, California
View Study & Checklist ➔MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
📍 Royal Prince Alfred Hospital — Camperdown, New South Wales
View Study & Checklist ➔Xenon MRI and Progressive ILD
📍 Duke University — Durham, North Carolina
View Study & Checklist ➔A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
📍 Keck School of Medicine at USC — Los Angeles, California
View Study & Checklist ➔Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
📍 Pulmonary Associates, PA — Mesa, Arizona
View Study & Checklist ➔Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
📍 Michelle F MacPherson — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Dose-Escalation Study of Artesunate Patients With IPF
📍 Stanford University — Stanford, California
View Study & Checklist ➔WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
📍 WISPer Site in Birmingham, AL — Birmingham, Alabama
View Study & Checklist ➔PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
📍 The University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
📍 Biosolutions Clinical Research — La Mesa, California
View Study & Checklist ➔Detection of Early Idiopathic Pulmonary Fibrosis
📍 Temple University — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
📍 The University of Alabama at Birmingham /ID# 277613 — Birmingham, Alabama
View Study & Checklist ➔A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔